Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep23 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

3-year setmelanotide weight outcomes in patients with bardet-biedl syndrome and obesity

Yanovski Jack , Angel Martos-Moreno Gabriel , Malhotra Sonali , Yuan Guojun , Chung Wendy , Dollfus Helene , Clement Karine

Background: Bardet-Biedl Syndrome (BBS) is a rare genetic disease in which impaired melanocortin-4 receptor (MC4R) signaling leads to hyperphagia and obesity. In an index Phase 3 trial, broad clinical benefit was observed in patients with BBS based on improvement or stabilization in ≥1 measure of weight, hunger, or quality of life with 1 year of treatment with the MC4R agonist setmelanotide. Reported here are long-term extension (LTE) weight outcomes after 3 years of set...

ea0099ep277 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Plasma SHBG levels as an early predictor of response to bariatric surgery

Gabriel-Medina Pablo , Ferrer Roser , Rodriguez-Frias Francisco , Comas Marta , Vilallonga Ramon , Ciudin Andreea , Selva David

Background: Obesity is a growing global health problem and currently bariatric surgery (BS) is the best solution in terms of sustained total weight loss (TWL). However, a significant number of patients present weight regain (WR) in time. There is a lack of biomarkers predicting the response to BS and WR during the follow-up. Plasma SHBG levels, which are low in obesity, increase one month after BS but there is no data of plasma SHBG levels at long term. We performed the presen...

ea0089c13 | Clinical – Chemo/SSA/Biologics | NANETS2022

Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization

Blanford Cole , Yan Donglin , Li Ning , Woodworth Alison , Gabriel Gaby , Khouli Riham El , Chauhan Aman , Anthony Lowell

Background: Chromogranin A (CGA) and 5-HIAA are meaningful biomarkers in managing neuroendocrine tumors (NETs). CGA, though nonspecific, can reflect disease bulk and typically decreases after debulking surgery. 5-HIAA is specific to NETs though its measurement may require a special diet, a 24-hour urine collection, or specialized blood collection tubes; but usually decreases after debulking procedures. Serotonin, though useful in diagnosing NETs, is not followed as a biomarker...

ea0090p74 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Assessment of insulin-releasing and glucose-lowering actions of aqueous extracts of Pterocarpus mildbraedii cellular and diet-induced mice models of type 2 diabetes

Ojo Opeolu , Benjamin Falana Ayokunle , Abiodun Falobi Ayodele , Kaur Heer Simren , Adie Mojisola , Nneka Edeani Joy , Anyanwu Gabriel , Ejike Uju

Aim: The use of commonly consumed vegetables, such as Pterocarpus mildbraedii, in the treatment of metabolic conditions is consistent with the food-as-medicine strategy. To characterise its pharmacological actions, this study assessed insulin-releasing and glucose lowering effects of effects of P. mildbraedii in models of type 2 diabetes.Methods: Clonal pancreatic cells, BRIN-BD11, were treated P. mildbraedii extracts...

ea0090p261 | Late-Breaking | ECE2023

Factored aldosterone can help distinguish mineralocorticoid resistance from aldosterone deficit hypoaldosteronism

Gabriel Ruiz Sanchez Jorge , Calle Alfonso , Angel Rubio Herrera Miguel , Paz de Miguel Novoa Maria , Gomez Hoyos Emilia , Runkle Isabel

Introduction: Hypoaldosteronism can be induced by a deficit of aldosterone production (AldDef) or a mineralocorticoid resistance (MinRes). Experts have proposed to use hyperkalemia-based aldosterone values for this purpose. However, there is no a range of aldosterone values indicating one of this type of hypoaldosteronism. In 2008, Adam W. R.1 hypothesized that the factored aldosterone (FAldo) could be useful differentiating hypoaldosteronism secondary to MinRes fro...

ea0049ep756 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Non-lipidic effects of PCSK9 inhibitors in real life

Gonzalez-Molero Inmaculada , Doulatram Viyu , Dominguez Marta , Torralvo Francisco Sanchez , Garcia Ignacio Ruiz , Olveira Gabriel , Tinahones Francisco

Objective: Analyse possible effects on physical examination, blood count, liver and kidney function, and steroidogenic hormones synthesis. Know the satisfaction of patients with the first injectable treatment for hypercholesterolemia approved in our country.Material and methods: Data were collected from patients with heterozygous familial hypercholesterolemia treated with PCSK9 inhibitors. Clinical, physical and analytical data were collected at baseline...

ea0041gp223 | Thyroid Cancer | ECE2016

Macro, but not micrometastases, detected by OSNA technique are related with more aggressive papillary thyroid cancer features

Zafon Carles , Iglesias Carmela , Gonzalez Oscar , Temprana Jordi , Caubet Enric , Garcia-Burillo Amparo , Obiols Gabriel , Serres Xavier , Mesa Jordi

Introduction: Classically, risk stratification in papillary thyroid carcinoma (PTC) assigned the same magnitude of risk to all patients with regional lymph node involvement (N1 disease). However, specific lymph node characteristics (such as size, number, extension, etc.) will allow individualizing treatment and follow-up. One-Step Nucleic Acid Amplification (OSNA) measures the number of copies of mRNA of cytokeratin 19 (CK19) as a marker of lymph node metastasis. Thus, copy nu...

ea0059cc2 | Featured Clinical Cases | SFEBES2018

Missplicing due to a silent exonic substitution in the T-box transcription factor TBX19 resulting in Isolated ACTH deficiency

Maudhoo Ashwini , Maharaj Avinaash , Buonocore Federica , Martos-Moreno Gabriel Angel , Argente Jesus , Achermann John , Chan Li , Metherell Lou

Background: Congenital isolated ACTH deficiency (IAD) is a rare condition characterised by low plasma ACTH and serum cortisol with normal production of other pituitary hormones. TBX19 is a T-box pituitary restricted transcription factor important for POMC gene transcription and terminal differentiation of POMC-expressing cells. TBX19 gene mutations have been shown to cause neonatal-onset congenital IAD. To date 25 mutations in TBX19 have been described, five ...

ea0035p719 | Neuroendocrinology | ECE2014

Effects of pharmacological blockade of glucocorticoids on energy homeostasis control by liver and pancreas in rats without pineal gland

Rodrigues Sandra Campos , Pantaleao Lucas Carminatti , de Araujo Veras Katherine M. , Amaral Fernanda Gaspar , Anhe Gabriel Forato , Bordin Silvana

In liver, melatonin (Mel) and glucocorticoids (GC) influence the systemic energy homeostasis. Animals without pineal gland present impairment in glycemic control, as in type-2 diabetes. In turn, Mel reduces the GC levels, particularly in nocturnal animals. We aimed to evaluate the influence of Mel, as well as GC receptor blockade by RU486 treatment on hepatic and pancreatic energy metabolism. Male Wistar rats were subjected to surgical removal of pineal and, 25 days after the ...

ea0032p252 | Clinical case reports – Pituitary/Adrenal | ECE2013

Non-Hodgkin’s lymphoma presenting as anterior hypopituitarism

Lee Shang Ming Samuel , Abel Chen Weiliang , Gabriel Cher Liu Yuan , Lee Wei Feng , Seow Cherng Jye , Kon YC

Introduction: Panhypopituitarism is a known but rare presentation of lymphoproliferative disease. We describe a patient with newly diagnosed advanced diffuse large B-cell lymphoma who presented with anterior hypopituitarism and concomitant adrenal gland involvement.Case report: A 72 year-old Chinese woman presented with a few weeks’ duration of lethargy, weight loss and functional decline. A hormonal screen done at admission suggested central hypoth...